We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Attorneys representing Par Pharmaceutical’s investors have filed a lawsuit after the company announced it would restate its previously reported financial results.